COMMUNIQUÉS West-GlobeNewswire

World Class Health Partners with GAM to Select and Directly Contract with Top Quality Surgeons
03/12/2025
NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- World Class Health (“WCH”), a global leader in medically led Centers of Excellence (CoE) networks, today announces their strategic partnership with Global Appropriateness [...]
Immuron New U.S. Department of Defense Award & Clinical Trial Update
03/12/2025
Highlights: New US Department of Defense award to develop two new oral therapeutics targeting Campylobacter and Shigella Uniformed Services University P2TD clinical study update MELBOURNE, Australia, Dec. 03, 2025 ( [...]
Greenwich LifeSciences Provides Global Update on FLAMINGO-01, Screening Over 1,000 Patients to Date
03/12/2025
STAFFORD, Texas, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is [...]
MUVON Therapeutics Reports Positive Phase 2 Results for its First-in-Class Muscle Precursor Cell (MPC)-based Tissue-Engineered Therapy Showing Clinically Meaningful and Statistically Significant Benefits in Stress Urinary Incontinence
03/12/2025
Zurich, Switzerland, December 03, 2025 – MUVON Therapeutics AG, a clinical-stage biotechnology company, reports positive topline results from the Phase 2 clinical trial SUISSE-MPC2 ( NCT05534269 ) evaluating its novel [...]
Curium Establishes Legal Entity in China
03/12/2025
Curium has established a legal entity in China which represents a major milestone in Curium’s international growth strategy and will enhance Curium’s ability to serve patients with cancer across Asia Curium’s local [...]
Actithera appoints radiopharmaceutical pioneer Dr. Darshan Dalal as Chief Medical Officer
03/12/2025
Internationally recognized radiopharmaceutical leader joins Actithera as the lead FAP-targeting asset advances to clinical development and the differentiated pipeline takes shape Brings over 15 years of global oncology [...]
Onco3R Therapeutics Announces Completion of First Multiple Ascending Dose Cohort in Phase 1 Trial of Novel SIK3 inhibitor O3R-5671
03/12/2025
Dosing of first MAD cohort in Phase 1 trial of O3R-5671 complete with no drug related adverse events Pharmacokinetic profile demonstrates long half-life and low intersubject variability Pharmacodynamic data from single [...]
Elevation Spine Center Expands Bend Clinic to Offer Easier Access to Advanced, Lasting Pain Relief
03/12/2025
Bend, OR, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Elevation Spine Center , one of the fastest-growing health clinics in Central Oregon, has completed a major expansion of its Bend facility. This expansion, finished on [...]
Disposal of 9 real estate assets in Belgium
03/12/2025
Press release December 3 rd , 2025 Disposal of 9 real estate assets in Belgium Paris, December 3 rd , 2025 - Clariane (CLARI.PA - ISIN FR0010386334) today announces that it has completed the sale of a real estate [...]
Cession de 9 actifs immobiliers en Belgique
03/12/2025
Communiqué de presse Cession de 9 actifs immobiliers en Belgique Paris, le 3 décembre 2025 Clariane (CLARI.PA – ISIN FR0010386334) : Clariane annonce aujourd’hui la cession d’un portefeuille d’actifs de santé situés en [...]
Inside information: Orion to receive EUR 180 million milestone and updates full-year outlook for 2025
03/12/2025
ORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION 3 DECEMBER 2025 at 09.00 EET Inside information: Orion to receive EUR 180 million milestone and updates full-year outlook for 2025 Orion Corporation has been [...]
Sapu Nano Unveils Broad-Applicability Deciparticle™ Nanomedicine Platform Capable of Formulating Multiple Hydrophobic Peptide, Macrolide, and Polyketide Drugs
03/12/2025
San Diego, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Sapu Nano , a clinical-stage nanomedicine company, today announced new data demonstrating that its proprietary Deciparticle ™ platform enables broad and consistent [...]
Kestra Medical Technologies, Ltd. Announces Pricing of Upsized Primary Public Offering of Common Shares
03/12/2025
KIRKLAND, Wash., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today announced the pricing of its upsized underwritten [...]
Clene to Provide CNM-Au8® ALS Program Update
02/12/2025
Webcast set for 8:30 a.m. ET on December 3rd SALT LAKE CITY, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a [...]
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/12/2025
MONTREAL and CHARLOTTE, N.C., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) (the “Company” or “Milestone”), today announced that the Company granted equity awards, in the form of a [...]
New Data Presented at the Clinical Trials on Alzheimer’s Disease (CTAD) Conference 2025 Confirms Pharmacological Effect of LEQEMBI® (lecanemab-irmb) on Neurotoxic Aβ Protofibrils in CSF
02/12/2025
TOKYO and CAMBRIDGE, Mass., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: [...]
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/12/2025
SAN FRANCISCO, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and [...]
Publication relating to transparency notifications
02/12/2025
REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), December 2, 2025 , 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Act of 2 May 2007 on the [...]
Publication relative à des notifications de transparence
02/12/2025
INFORMATION RÉGLEMENTÉE Publication relative à des notifications de transparence Mont-Saint-Guibert (Belgique), le 2 décembre 2025 , 22:30h CET / 16:30h ET – Conformément à l'article 14 de la loi du 2 mai 2007 relative [...]

Pages